Physician assessment of stroke risk in hypertensive patients in the Middle East and Africa: Results of the action survey

Ethnicity and Disease

Volumn 17, Issue 2, 2007, Pages 274-279

  Badr, Kamal F ^a   Merad Boudia, Khereddine M ^b   Alami, Mohamed ^c   Khoja, Waleed A ^d   Belhani, Ali B ^e   Nawar, Moustafa ^f   Ragy, Hany ^g   Ishaq, Mohammad ^g   Muscat Baron, J M ^h   Hammoudeh, Ayman J ⁱ   De Mar Youssef, Suzan S ⁱ   Nakhle, Reine M ⁱ   Chalfoun, Amale G ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b CHU Mustapha   (Algeria)

^c Riyadh Armed Forces Hospital ^*

^d The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^e CHARLES NICOLLE HOSPITAL   (Tunisia)

^f ALEXANDRIA UNIVERSITY   (Egypt)

^g NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Pakistan)

^h Al Essra Hospital   (Jordan)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Africa; Cardiovascular risk factors; Framingham heart study; Middle East; Stroke

Indexed keywords

ADULT; AFRICA; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTICENTER STUDY; POPULATION RISK; RISK FACTOR; SCORING SYSTEM; SMOKING; STROKE;

AFRICA; AGED; CEREBROVASCULAR ACCIDENT; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MIDDLE EAST; PHYSICIANS; RISK ASSESSMENT; RISK FACTORS;

EID: 34447509690     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mackay J, Mensah GA. The atlas of heart disease and stroke. Available at: http://www.who.int/cardiovascular_diseases/en/cvd_adas_16_death_from_stroke. pdf. Last accessed 9/1/06.
2. Mancia G. Prevention and treatment of stroke in patients with hypertension. Clinical Therapeutics. 2004;26:631-648.
3. Goldstein L, Adams R, Becker K, et al. Primary prevention of ischemic stroke. Stroke. 2001;32:280-299.
4. Lawes C, Bennett D, Feigin V, Rodgers A. Blood pressure and stroke. An overview of published reviews. Stroke. 2004;35:1024-1033.
5. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
6. Li C, Engström G, Hedblad B, Berglund G, Janzon L. Blood pressure control and risk of stroke. A population-based prospective cohort study. Stroke. 2005;36:725-730.
7. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens. 2005;23:1575-1581.
8. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
9. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonist and other blood pressure lowering drugs: results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Trialists' Collaboration. Lancet. 2000;356:1955-1964.
10. Hansson L, Lindholm L, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular morality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999;354:1751-1756.
11. Dahlöf B, Devereux R, Kjeldsen S, et al. Cardiovascular morbidity and morality in Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359:995-1003.
12. Al-Rajeh S, Larbi E, Bademosi O, Awada A, Ismail H, Al-Freihi H. Pattern and ethnic variations in stroke in Saudi Arabia. J Neurol Sci. 1991;102:112-118.
13. Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Stroke in the young: incidence and pattern in Benghazi, Libya. Acta Neurol Scand. 1986;73:434-438.
14. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26:361-367.
15. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention. JAMA. 2002;288:1388-1395.
16. Staessen J, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA. 2003;289:2420-2422.
17. Giroud M, Beuriat P, Vion P, D'Athis P.H, Dusserre L, Dumas R. Stroke in a French prospective population study. Neuroepidemiology. 1989;8:97-104.
18. Sudlow CL, Warlow CP. Comparable Studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28:491-499.
19. Bastuji-Garin S, Deverly A, Moyse D, et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens. 2002;20:1973-1980.